Open Access<p>Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study</p>
Author(s) -
Andrea CasadeiGardini,
Emanuela Scarpi,
Paola Ulivi,
M. A. Palladino,
Caterina Accettura,
Ilaria Bernardini,
Andrea Spallanzani,
Fabio Gelsomino,
Jody Corbelli,
Giorgia Marisi,
Silvia Ruscelli,
Martina Valgiusti,
Giovanni Luca Frassineti,
Alessandro Passardi
Publication year - 2019
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
ISSN - 1179-1322
DOI - 10.2147/cmar.s198651
Subject(s) - bevacizumab , medicine , colorectal cancer , gastroenterology , lactate dehydrogenase , neutrophil to lymphocyte ratio , oncology , chemotherapy , regimen , cancer , lymphocyte , biochemistry , chemistry , enzyme